[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
作者信息
Buhl R
机构信息
III. Medizinische Klinik, Klinikum der Johannes Gutenberg-Universität Mainz, 55131 Mainz.
出版信息
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25.
PMID:19941241
Abstract
摘要
相似文献
1
[Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?].
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S381-5. doi: 10.1055/s-0029-1243046. Epub 2009 Nov 25.
2
[Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?].
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S376-80. doi: 10.1055/s-0029-1243045. Epub 2009 Nov 25.
3
[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S386-9. doi: 10.1055/s-0029-1243047. Epub 2009 Nov 25.
4
Asthma.
Clin Evid. 2002 Jun(7):1325-43.
5
[Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S394-7. doi: 10.1055/s-0029-1243049. Epub 2009 Nov 25.
6
[Do fixed combinations increase effectiveness in asthma bronchiale?].
Dtsch Med Wochenschr. 2009 Dec;134 Suppl 10:S372-5. doi: 10.1055/s-0029-1243044. Epub 2009 Nov 25.
7
8
[Modern management of asthma].
MMW Fortschr Med. 2009 Nov 19;151(47):38, 40-2; quiz 43.
9
[Long-acting beta 2-agonists in addition to inhaled corticosteroids in children and adults with chronic asthma. A survey of two Cochrane reviews].
Ugeskr Laeger. 2007 Mar 12;169(11):997-1001.
10
An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids.
Expert Opin Drug Saf. 2010 May;9(3):407-19. doi: 10.1517/14740330903535852.
Zotero 插件